Navigation Links
VAP Cholesterol Test From Atherotech Covers 90 Percent of Arizona Insured
Date:2/6/2008

Comprehensive Cholesterol Test Can Help Identify Patients At Risk of Heart

Disease and Diabetes

BIRMINGHAM, Ala., Feb. 6 /PRNewswire/ -- Atherotech, Inc., a cardio-diagnostic company, today announced that the largest private insurers in Arizona as well as Medicare, Medicaid and the Federal Employees Health Benefits (FEHB) Program now cover the VAP (Vertical Auto Profile) Test, the most comprehensive cholesterol test available. That means almost 90 percent of all insured lives in Arizona now have insurance coverage for the VAP Test, which finds twice as many people at risk than the standard cholesterol test.

"The state of Arizona is extremely progressive in preventive health," said Atherotech Chief Medical Officer James Ehrlich, M.D. "The highly accurate VAP Test allows the clinician to target high-risk patients for specific therapy that could help prevent millions of future heart attacks and strokes. I am confident that the VAP Test will continue to be regarded as the best and most cost-effective laboratory method to precisely identify vulnerable individuals who may be at risk for the nation's leading killer, cardiovascular disease."

People with a family history or an existing condition of diabetes, high blood pressure or heart disease -- or who are already taking cholesterol lowering medication -- are candidates for the comprehensive VAP Test. In addition, those who didn't score within the desirable ranges of the standard cholesterol test (i.e. those with Triglycerides > 150, HDL < 40, LDL >130, Total Cholesterol > 200) should also opt for the more detailed VAP Test.

"The VAP cholesterol test allows a detailed analysis of all lipid parameters to obtain an accurate and predictive risk for CVD," said Richard Fowler, M.D., of the Arizona Center for Internal Medicine.

The VAP Test is the first cholesterol test to identify markers for Metabolic Syndrome, a precursor for diabetes. The VAP Test directly
'/>"/>

SOURCE Atherotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
2. Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
3. Phase 1 Studies Show Promise of QuatRxs Novel Compound, Sobetirome, for Lowering LDL Cholesterol Levels
4. Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination
5. Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy
6. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
7. 454 sequencing uncovers significant genetic variation
8. Medical Breakthrough ... Doctor Discovers Penetrating Carrier That Eradicates Fungus
9. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
10. The Center for Molecular Medicine Doubles Lab Staff, Expands Lab Space by 100 Percent
11. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... serious infectious diseases, announced today that Jeffrey Riley , ... New York Conference on Thursday, June 27, 2013 at The ... Mr. Riley is scheduled to present at 8:40 a.m. (Eastern ... can be accessed by logging onto the web at ...
(Date:6/19/2013)... WASHINGTON, D.C. (PRWEB) June 19, 2013 ... with its first Bayer Bee Care Community Leadership Award. ... Pollinator Week Congressional Reception in Washington, D.C., an ... pollinators make to the world’s food supply. , ... who have harnessed the power of the honey bee ...
(Date:6/19/2013)... Bloomington, Indiana (PRWEB) June 19, 2013 ... Valentine joined the speaking faculty at 2013’s BioLogistics ... , The conference, coordinated by Cold Chain IQ ... surrounding biologics. This “complexity” is, in part, attributed ... medicine. , “Implicit within these trends is ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Express Diagnostics ... tests, today announced that it has received Class III ... and sell its DrugCheck® NxStep Onsite Drug Screen ... of the rapid screening device in near-patient settings, such ... Screen Cup received Health Canada Class III approval for ...
Breaking Biology Technology:Synthetic Biologics to Present at OneMedForum New York 2013 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
... Merrimack Pharmaceuticals, Inc., a privately held biotechnology company focused ... cancer and autoimmune disease, today announced that Ulrik B. ... Chief Scientific Officer and Edward (Tad) J. Stewart to ... Tad have both played critical roles in building ...
... 9 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.,(NYSE Alternext US: ... in,China, announced today that the Chinese government, led ... the Ministry of Finance and the State,Administration of ... Co. Ltd.(Sinovac Beijing), high-tech enterprise status.,According to the ...
... BioStorage Technologies, Inc. (BST), a worldwide provider of long- ... chain logistics, announces the recent promotion of Lori Ball ... joined BioStorage Technologies in 2007 as Vice President of ... as well as corporate branding and domestic and international ...
Cached Biology Technology:Merrimack Pharmaceuticals Promotes Ulrik B. Nielsen, Ph.D. to Chief Scientific Officer and Edward J. Stewart to Senior Vice President of Business Development 2Sinovac Biotech Co. Ltd., Sinovac's Beijing Subsidiary, Obtains High-Tech Enterprise Status 2Sinovac Biotech Co. Ltd., Sinovac's Beijing Subsidiary, Obtains High-Tech Enterprise Status 3BioStorage Technologies, Inc. Promotes Lori Ball to Senior Vice President and Expands Role 2
(Date:6/19/2013)... A team of researchers at the University of ... outer coating of HIV, that could be potential ... avoid generating resistance. These new agents are quite ... The research was published in the June 2013 ... Chemotherapy . , The first of many probable ...
(Date:6/19/2013)... , June 19, 2013 MedNet Solutions ... clinical study management systems, is pleased to announce its ... held June 23-27 in Boston . ... a recognized leader in cloud-based eClinical solutions, has exhibited ... be showcasing iMedNet™ EDC , MedNet,s ...
(Date:6/19/2013)... is the most potent physiological anabolic agent for ... synthesis of lipids, protein and carbohydrates, and inhibiting ... It also plays a major role in stimulating ... is metabolized and removed from the blood following ... molecular mechanisms by which insulin regulates glucose uptake ...
Breaking Biology News(10 mins):HIV-derived antibacterial shows promise against drug-resistant bacteria 2MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2
... dark shadow of a mushroom cloud rising above a decimated ... imagination more than the prospect of bioterrorism. Yet, ten years ... of a threat do bioterrorist attacks represent and how prepared ... Bioterrorism Defense, 2nd Edition Dr Rebecca Katz and Dr Raymond ...
... the atmosphere to grow, so forests have long been proposed ... than just letting the forest sit there for a hundred ... of the atmosphere could be quadrupled in 100 years by ... and concrete that devour fossil fuels during manufacturing, producing carbon ...
... July 14, 2011 ,   ... consumer wellness applications,today announced that it has entered into an ... Million equity,line facility. Under the terms of the ... the option to sell and Dutchess the,obligation to purchase common ...
Cached Biology News:'Encyclopedia of Bioterrorism Defense,' 2nd edition 2Wood products part of winning carbon-emissions equation, researchers say 2Wood products part of winning carbon-emissions equation, researchers say 3SPO Secures Equity Line Facility of US$5 Million 2SPO Secures Equity Line Facility of US$5 Million 3SPO Secures Equity Line Facility of US$5 Million 4
... Epithelial and endothelial cells-directed ... a RGD peptide-conjugated polyethylenimine which ... integrin-expressing epithelial and endothelial cells. ... in cell-cell and cell-matrix adhesion ...
... WinMelt software is used to ... any DNA sequence up to ... optimizing placement of primers and ... by denaturing gradient gel electrophoresis ...
Request Info...
... Accurate To score SNPs, ... sequencing, the gold standard in DNA analysis. ... The polymorphic locus can be confirmed by ... DNA sequencing also provides sequence context information, ...
Biology Products: